Patents by Inventor Albert Thom

Albert Thom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220306754
    Abstract: The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
    Type: Application
    Filed: March 17, 2022
    Publication date: September 29, 2022
    Inventors: Josquin NYS, Albert THOM, Peter CARIUK, Darren SCHOFIELD, Aidan RILEY, Catherine HUNTINGTON, David REES, Lorraine IRVING, Matthew ROBINSON
  • Publication number: 20080107658
    Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralise NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.
    Type: Application
    Filed: January 24, 2006
    Publication date: May 8, 2008
    Inventors: Ruth Franks, Andrew Buchanan, Albert Thom, Fraser Welsh, Philip Bland-Ward, Matthew Sleeman, Carl Matthews, Celia Hart, Jon Hawkinson
  • Publication number: 20070243589
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.
    Type: Application
    Filed: February 20, 2007
    Publication date: October 18, 2007
    Inventors: Davinder Gill, Jing Li, Geertruida Veldman, Lynette Fouser, Viia Valge-Archer, David Lowe, Caroline Russell, Suzanne Cohen, Albert Thom, Ralph Minter